Overview

Topical Cyclosporine and Disease Progression

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.
Phase:
Phase 4
Details
Lead Sponsor:
Innovative Medical
Treatments:
Cyclosporine
Cyclosporins